Combination of radiotherapy and targeted therapy for HER2-positive breast cancer brain metastases

Radiotherapy and targeted therapy are essential treatments for patients with brain metastases from human epidermal growth factor receptor 2 (HER2)-positive breast cancer. However, the combination of radiotherapy and targeted therapy still needs to be investigated, and neurotoxicity induced by radiot...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Xiaojing, Ren, Hanru, Xu, Yi, Peng, Xue, Yu, Wenxi, Shen, Zan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9841677/
https://www.ncbi.nlm.nih.gov/pubmed/36642742
http://dx.doi.org/10.1186/s40001-022-00894-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9841677/
https://www.ncbi.nlm.nih.gov/pubmed/36642742
http://dx.doi.org/10.1186/s40001-022-00894-7

Ejemplares similares